PB2110: PHARMACOKINETICS AND PHARMACODYNAMICS IN FIRST-MIND: A PHASE IB, OPEN-LABEL, RANDOMIZED STUDY OF TAFASITAMAB ± LENALIDOMIDE + R-CHOP IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA. (23rd June 2022) - Belada, D.; Kopeckova, K.; Bergua Burgues, J. M.; Stevens, D.; Nowakowski, G. S.; Waldron-Lynch, M.; Hadar, N.; Weirather, J.; Lässig, C.; Blair, D.; Dreyling, M.